Dose escalation in early nonresponders to 80 mg/day of lurasidone: The Optimize study; Presented at the annual meeting of the American College of Neuropsychopharmacology
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.